Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Campain

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
BMC Medical Genomics|April 2, 2011
Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profilingTo Ha Loi, Anna Campain, Adam Bryant, et al.
Frontiers in Pharmacology|April 11, 2022
Integrating Pharmacy and Registry Data Strengthens Clinical Assessments of Patient AdherenceSarah Serhal, Carol Armour, Laurent Billot, et al.
The British Journal of Ophthalmology|November 6, 2015
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trialHemal Mehta, Samantha Fraser-Bell, Aaron Yeung, et al.
Clinical & Experimental Ophthalmology|July 27, 2018
No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort studyMartin G Lee, Nathaniel S Marshall, Traci E Clemons, et al.
Ophthalmology|January 20, 2016
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)Samantha Fraser-Bell, Lyndell L Lim, Anna Campain, et al.
Ophthalmology|August 27, 2014
A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX studyMark C Gillies, Lyndell L Lim, Anna Campain, et al.
Retina (Philadelphia, Pa.)|February 2, 2017
TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONDaniel Barthelmes, Vuong Nguyen, Vincent Daien, et al.
Ophthalmology|June 23, 2015
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational StudyMark C Gillies, Anna Campain, Daniel Barthelmes, et al.
Ophthalmology|April 8, 2015
Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degenerationJennifer J Arnold, Anna Campain, Daniel Barthelmes, et al.
BMJ Open|July 23, 2025
An assessment of data quality and sociodemographic variation in health service utilisation of general practice, emergency department and admitted services in a New South Wales linked health data asset: a retrospective cohort study of LumosTristan Bouckley, Rimma Myton-Katieva, David Peiris, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
BMC Medical Genomics|April 2, 2011
Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profilingTo Ha Loi, Anna Campain, Adam Bryant, et al.
Frontiers in Pharmacology|April 11, 2022
Integrating Pharmacy and Registry Data Strengthens Clinical Assessments of Patient AdherenceSarah Serhal, Carol Armour, Laurent Billot, et al.
The British Journal of Ophthalmology|November 6, 2015
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trialHemal Mehta, Samantha Fraser-Bell, Aaron Yeung, et al.
Clinical & Experimental Ophthalmology|July 27, 2018
No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort studyMartin G Lee, Nathaniel S Marshall, Traci E Clemons, et al.
Ophthalmology|January 20, 2016
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)Samantha Fraser-Bell, Lyndell L Lim, Anna Campain, et al.
Ophthalmology|August 27, 2014
A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX studyMark C Gillies, Lyndell L Lim, Anna Campain, et al.
Retina (Philadelphia, Pa.)|February 2, 2017
TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONDaniel Barthelmes, Vuong Nguyen, Vincent Daien, et al.
Ophthalmology|June 23, 2015
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational StudyMark C Gillies, Anna Campain, Daniel Barthelmes, et al.
Ophthalmology|April 8, 2015
Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degenerationJennifer J Arnold, Anna Campain, Daniel Barthelmes, et al.
BMJ Open|July 23, 2025
An assessment of data quality and sociodemographic variation in health service utilisation of general practice, emergency department and admitted services in a New South Wales linked health data asset: a retrospective cohort study of LumosTristan Bouckley, Rimma Myton-Katieva, David Peiris, et al.
Pageof 4